Accretive Wealth Partners’s iShares iBonds Dec 2029 Term Treasury ETF IBTJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.33M Buy
251,175
+49,240
+24% +$1.06M 1.14% 22
2026
Q2
$4.37M Buy
201,935
+36,777
+22% +$798K 1.06% 19
2026
Q1
$3.61M Buy
165,158
+10,467
+7% +$230K 1.01% 23
2025
Q4
$3.39M Buy
154,691
+3,984
+3% +$87.6K 1.01% 26
2025
Q3
$3.31M Buy
150,707
+3,231
+2% +$70.7K 1.01% 26
2025
Q2
$3.23M Buy
147,476
+6,791
+5% +$148K 1.06% 25
2025
Q1
$3.06M Buy
140,685
+29,729
+27% +$639K 1.08% 22
2024
Q4
$2.37M Buy
110,956
+1,392
+1% +$30K 1% 23
2024
Q3
$2.42M Buy
109,564
+1,886
+2% +$41.2K 1.01% 26
2024
Q2
$2.3M Buy
107,678
+1,362
+1% +$28.9K 0.96% 27
2024
Q1
$2.25M Buy
106,316
+7,220
+7% +$156K 1% 23
2023
Q4
$2.16M Buy
+99,096
New +$2.1M 1.04% 23

Other funds holding IBTJ

Accretive Wealth Partners's IBTJ Position: Q3 2026 in Review

Accretive Wealth Partners increased its iShares iBonds Dec 2029 Term Treasury ETF (IBTJ) stake by 24% in Q3 2026, buying an estimated $1.06M and bringing the position to 251,175 shares worth $5.33M. The position accounts for 1.14% of the portfolio, ranked #22.

Accretive Wealth Partners first reported a position in IBTJ in Q4 2023 and has held it in 12 quarters since. 132 funds tracked by Wall St. Rank hold IBTJ as of Q3 2026.

  • Accretive Wealth Partners held 251,175 shares of iShares iBonds Dec 2029 Term Treasury ETF worth $5.33M as of Q3 2026.
  • Accretive Wealth Partners bought 49,240 iShares iBonds Dec 2029 Term Treasury ETF shares in Q3 2026, an estimated $1.06M.
  • iShares iBonds Dec 2029 Term Treasury ETF made up 1.14% of Accretive Wealth Partners's portfolio in Q3 2026, its #22 holding.
  • Accretive Wealth Partners first reported a position in iShares iBonds Dec 2029 Term Treasury ETF in Q4 2023 and has held it in 12 quarters since.
  • 132 funds tracked by Wall St. Rank held iShares iBonds Dec 2029 Term Treasury ETF as of Q3 2026.

Based on Accretive Wealth Partners's 13F filing for Q3 2026, filed 6 Nov 2026.